InMed Pharmaceuticals Inc.
USD1.55
-0.02 (-1.59%)
CEO
Eric A. Adams Chem.
IPO Date
2014-05-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CA
Open
$1.53
Prev. Close
$1.57
Day Low
$1.53
Day High
$1.57
52W Low
$0.57
52W High
$3.28
Market Cap
$0.00B
Volume
0.01M
| -0.2 |
| 30 Jun 2023 | FY | 33.9% | -192.2% | -49.6% | -42.5% | 0.03 | 5.66 | -0.3 |
| 30 Jun 2022 | FY | 49.9% | -1707.3% | -159.1% | -113.0% | 0.09 | 2.89 | -0.0 |
| 30 Jun 2021 | FY | 0.0% | 0.0% | -138.7% | -104.6% | 0.04 | 3.78 | -1.7 |
| 30 Jun 2020 | FY | 0.0% | 0.0% | -152.1% | -114.6% | 0.05 | 3.77 | -4.9 |
| 30 Jun 2019 | FY | 0.0% | 0.0% | -72.1% | -66.4% | 0.00 | 11.87 | -5.7 |
| 30 Jun 2018 | FY | 0.0% | 0.0% | -43.1% | -41.6% | 0.00 | 28.51 | -12.1 |
| 30 Jun 2017 | FY | 0.0% | 0.0% | -56.2% | -53.7% | 0.00 | 18.79 | -9.3 |
| 30 Jun 2016 | FY | 0.0% | 0.0% | -223.9% | -143.9% | 0.00 | 0.32 | -3.3 |
| -0.0 |
| 30 Sept 2025 | Q1 | 36.0% | -154.2% | -10.7% | -9.3% | 0.06 | 6.95 | -0.0 |
| 30 Jun 2025 | Q4 | 44.2% | -137.1% | -13.3% | -11.5% | 0.06 | 6.99 | -0.7 |
| 31 Mar 2025 | Q3 | 13.9% | -168.1% | -21.2% | -16.0% | 0.12 | 3.49 | -0.3 |
| 31 Dec 2024 | Q2 | 41.5% | -231.6% | -29.0% | -21.1% | 0.15 | 3.05 | -0.3 |
| 30 Sept 2024 | Q1 | 39.0% | -132.7% | -14.7% | -11.8% | 0.13 | 5.07 | -0.4 |
| 30 Jun 2024 | Q4 | 36.3% | -151.0% | -15.4% | -12.0% | 0.10 | 4.41 | -0.3 |
| 31 Mar 2024 | Q3 | 24.7% | -146.9% | -11.4% | -9.5% | 0.10 | 6.58 | -0.5 |
| 31 Dec 2023 | Q2 | 26.1% | -119.2% | -8.7% | -7.3% | 0.09 | 7.03 | -0.6 |